EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment

Jinxin Che, Shaowei Bing, Jialiang Lu, Zegao Jin, Jian Gao, Haichao Sheng, Dan Li, Bo Yang, Qiaojun He, Meidan Ying, Xiaowu Dong iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c00829 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Jinxin Che und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou …. Hauptthemen laut MEDLINE: Neuroblastoma, Proto-Oncogene Proteins c-akt, Oxazepines, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Primary Research and Development Plan of Zhejiang Province, Science Fund for Distinguished Young Scholars of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with high-risk neuroblastoma face limited treatment choices, typically involving a combination of cytotoxic and differentiation maintenance therapies due to a scarcity of drugs. Evidence suggests that targeted inhibitors may provide opportunities for inducing neuroblastoma differentiation while inhibiting proliferation. Here, we demonstrate the synergistic effect of inhibiting Akt and ROCK in antineuroblastoma and present the design and discovery of a new Akt/ROCK inhibitor, B12. It displays strong antiproliferative effects and excellent differentiation inducing activity against Neuro2a cells. Treatment with B12 results in the arrest of G0/G1 cell cycles, a significant decrease in N-myc protein level, and an increase in differentiation markers. The administration of B12 effectively suppresses xenograft tumor growth and promotes differentiation. Overall, the discovery of B12 based on the Akt/ROCK dual inhibition strategy may provide hope for the development of more effective and targeted therapies for this challenging disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaProto-Oncogene Proteins c-aktOxazepinesAntineoplastic AgentsProtein Kinase Inhibitorsrho-Associated KinasesHumansAnimalsCell DifferentiationCell ProliferationCell Line, TumorMiceDrug DiscoveryStructure-Activity RelationshipXenograft Model Antitumor AssaysMice, Nude

Substanzen

Proto-Oncogene Proteins c-aktOxazepinesAntineoplastic AgentsProtein Kinase Inhibitorsrho-Associated Kinases

Autor:innen und Institutionen

  • Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.
  • Innovation Institute for Artificial Intelligence in Medicine, Zhejiang University, Hangzhou 310058, China.
  • Cancer Center, Zhejiang University, Hangzhou 310058, China.
  • Pediatric Cancer Research Center, National Clinical Research Center for Child Health, Hangzhou 310052, China.

ORCID-Profile: Xiaowu Dong

Förderung

  • Primary Research and Development Plan of Zhejiang Province
  • Science Fund for Distinguished Young Scholars of Zhejiang Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province

Zitieren

APA

Che, J., Bing, S., Lu, J., Jin, Z., Gao, J., Sheng, H., Li, D., Yang, B., He, Q., Ying, M., & Dong, X. (2023). Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00829

Vancouver

Che J, Bing S, Lu J, Jin Z, Gao J, Sheng H, et al. Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00829

BibTeX
@article{Che2023,
  author = {Che, Jinxin and Bing, Shaowei and Lu, Jialiang and Jin, Zegao and Gao, Jian and Sheng, Haichao and Li, Dan and Yang, Bo and He, Qiaojun and Ying, Meidan and Dong, Xiaowu},
  title = {Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma Treatment},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c00829}
}
Kostenlos starten →